Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

122
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
122
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

148
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
148

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ambulatory Stage C2D Heart Failure Definitions and Current Therapeutic Approaches: JACC: Heart Failure Position Statement.

JACC. Heart failure·2026
Same author

Attitudes and Perspectives on Shared Decision Making Among Breast Surgical Oncologists: A Qualitative Study.

Annals of surgical oncology·2026
Same author

ASO Visual Abstract: Attitudes and Perspectives on Shared Decision-Making Among Breast Surgical Oncologists-A Qualitative Study.

Annals of surgical oncology·2026
Same author

Understanding of Prognosis and Estimation of Mortality in Ambulatory Patients With Heart Failure.

JAMA network open·2026
Same author

Trends in cannabis urine drug screen testing in Colorado's largest health system: a retrospective cohort study.

Journal of cannabis research·2026
Same author

Development and acceptability of a deep brain stimulation surgery decision aid for Parkinson's disease.

Journal of Parkinson's disease·2026

Related Experiment Video

Updated: Nov 19, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.1K

Shared Decision-Making for Left Ventricular Assist Devices: Rationale and Design of a Nationwide Dissemination and

Jocelyn S Thompson1, Monica D Fitzgerald1, Larry A Allen1,2

  • 1Adult and Child Consortium for Health Outcomes Research and Delivery Science (J.S.T., M.D.F., L.A.A., C.K.M., R.E.G., M.A.M., D.D.M.), University of Colorado School of Medicine, Aurora, CO.

Circulation. Cardiovascular Quality and Outcomes
|February 3, 2021
PubMed
Summary
This summary is machine-generated.

A decision aid for left ventricular assist devices (LVADs) improves decision quality for heart failure patients and caregivers. This study disseminates the aid nationwide to enhance complex medical choices.

Keywords:
caregiverdiffusion of innovationsheart-assist devices heart failureimplementation sciencemaintenance

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.9K
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.7K

Related Experiment Videos

Last Updated: Nov 19, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.1K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.9K
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.7K

Area of Science:

  • Cardiology
  • Medical Device Technology
  • Health Services Research

Background:

  • Left ventricular assist device (LVAD) implantation is a critical treatment for end-stage heart failure, presenting complex decisions for patients and caregivers.
  • While LVADs improve survival, they involve significant risks and lifestyle adjustments, necessitating high-quality decision-making support.
  • Prior research demonstrated an LVAD decision aid's effectiveness in enhancing decision quality and successful implementation in six LVAD programs.

Purpose of the Study:

  • To conduct a nationwide dissemination and implementation project for an established LVAD decision aid.
  • To implement the decision aid across as many of the 176 LVAD programs in the United States as feasible.
  • To serve as a model for disseminating other evidence-based decision support tools.

Main Methods:

  • Utilizing the Theory of Diffusion of Innovations framework across four project phases: network building, adoption promotion, implementation support, and maintenance encouragement.
  • Establishing a national LVAD clinician network through surveys, professional relationships, and online strategies.
  • Providing resources to promote adoption and integrate the decision aid into standard LVAD education, with evaluation via the RE-AIM framework.

Main Results:

  • The project targets all 176 US LVAD programs for broad dissemination.
  • Social marketing principles are uniquely employed to drive adoption and implementation of the decision aid.
  • Evaluation metrics include reach, effectiveness, adoption, implementation, and maintenance, assessed through clinician and patient surveys and interviews.

Conclusions:

  • This nationwide dissemination study aims to maximize the reach of an effective LVAD decision aid.
  • The project's innovative approach uses social marketing to facilitate the adoption and implementation of decision support tools.
  • The developed implementation plan offers a scalable model for disseminating other evidence-based decision aids in healthcare.